KMT2A and myeloid neoplasm: Although TP53 mutations rarely coexist with MLL-fusions and ASXL1 mutations, nonmutational p53 dysfunction could contribute to the development of myeloid neoplasms with MLL-rearrangements or ASXL1 mutations.